Your fertility is declining in your 30s. Your genes may explain why.

MTHFR encodes an enzyme that converts folate into its active form, methylfolate. This active form is essential for methylation reactions throughout your body, including the creation of DNA and RNA. In your reproductive system, methylation is critical for regulating gene expression in developing embryos and for maintaining healthy egg quality.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces this enzyme’s activity by 40 to 70%. That means your cells are converting dietary folate into usable forms at a fraction of the rate they should be. Your eggs may develop with impaired methylation patterns, and embryos may struggle to establish the precise gene expression needed for normal development and implantation.

In your 30s, this matters intensely. Declining methylation capacity accelerates the rate of egg quality decline. If you’ve had miscarriages, poor embryo quality during IVF, or unexplained implantation failure despite normal hormone levels and uterine anatomy, a MTHFR variant is often the hidden cause.

FSHR encodes the follicle-stimulating hormone receptor, which sits on the surface of egg-containing follicles in your ovaries. When FSH binds to this receptor, it tells your ovaries to grow and mature eggs. The variant that matters most is N680S, where your body either expresses a more sensitive version (S/S) or a less sensitive version.

If you carry the S/S variant, found in roughly 10 to 15% of women, your ovarian follicles are less responsive to FSH stimulation. Your ovaries require higher doses of hormone to generate the same number of mature eggs. The same FSH dose that works beautifully for other women may produce a weak response in you, making pregnancy harder to achieve naturally and IVF stimulation less efficient.

In your 30s, this becomes visible as declining ovarian reserve or poor response to fertility treatment. You may have normal FSH levels but still feel frustrated with ovarian response. Your doctor may recommend higher medication doses without realizing a genetic variant is the real issue.

ESR1 encodes estrogen receptor alpha, the primary estrogen receptor in your uterus, ovaries, and bone. Estrogen sensitivity controlled by ESR1 determines whether your endometrium develops properly to receive an embryo, and whether your ovaries respond optimally to estrogen’s feedback signals during the cycle.

Common variants in ESR1 (PvuII and XbaI polymorphisms) affect the sensitivity of your estrogen receptor. Roughly 40% of women carry variants that reduce receptor sensitivity. This means your uterine lining may not develop optimally for implantation, and your endometrial receptivity window may be narrower or shifted compared to women with other variants, making embryo implantation less likely even with a genetically normal embryo.

In your 30s, ESR1 variants show up as repeated implantation failure during IVF, unexplained infertility despite normal egg and sperm quality, or sensitivity to estrogen-based hormonal treatments. You may have a beautiful endometrium on ultrasound and still not conceive.

COMT encodes catechol-O-methyltransferase, an enzyme that inactivates and clears estrogen from your bloodstream. Efficient estrogen clearance keeps estrogen levels in a healthy range. Slow estrogen clearance allows estrogen to accumulate, triggering inflammation, endometriosis, and reduced egg quality.

The COMT Val158Met variant is extremely common. Roughly 25% of people with European ancestry are homozygous for the slow version. Slow COMT means estrogen lingers in your bloodstream longer, and chronically elevated estrogen drives endometriosis, PCOS-like symptoms, and accelerated egg aging. Your ovaries experience constant excessive estrogen exposure, which damages egg DNA and reduces quality.

In your 30s, slow COMT often manifests as worsening endometriosis, heavy or painful periods, declining egg quality despite normal-looking ovarian reserves, or PCOS symptoms that don’t fit the typical mold. You may have been told your fertility issues are inflammatory or hormonal without anyone testing whether your estrogen metabolism is actually dysfunctional.

VDR encodes the vitamin D receptor, which controls how your cells respond to vitamin D signaling. Vitamin D is not just about bone health; it’s a critical immune regulator. Your immune system must tolerate a developing embryo while still fighting infections. VDR variants determine whether your immune regulation works properly during this delicate balance.

Common VDR variants (FokI, BsmI, ApaI, TaqI) reduce vitamin D receptor function. Women carrying certain VDR variants have impaired immune tolerance and elevated inflammatory markers during reproductive years. Even with adequate vitamin D blood levels, poor VDR function means your immune system may attack developing embryos or prevent proper follicle development, reducing fertility without any obvious cause.

In your 30s, VDR variants show up as recurrent miscarriage, poor egg quality despite other markers looking normal, or unexplained infertility with subtle inflammatory signs. Your vitamin D level may look fine, but your cells aren’t responding to it properly.

FMR1 encodes the fragile X mental retardation protein, which regulates gene expression in fragile X syndrome. But FMR1 also controls ovarian reserve and longevity. Premutation alleles in FMR1, carrying 55 to 200 CGG repeats instead of the normal 5 to 44, are associated with premature ovarian insufficiency (POI), where your ovaries age faster than expected.

Roughly 1 in 250 women carry a premutation allele. Carriers may experience rapid declines in ovarian reserve, elevated FSH before age 40, and shorter reproductive windows than their age and baseline reserve would predict. Your ovarian aging may be accelerating silently; your follicle count may decline faster than typical age-related decline, and you may reach functional menopause years earlier than expected.

In your 30s, FMR1 premutations show up as unexpectedly poor ovarian reserve for your age, climbing FSH despite earlier normal levels, or a family history of early menopause. You feel like your fertility is dropping off a cliff, and standard tests suggest your ovaries are aging unusually fast.